SCHEMBL9200232

SCHEMBL9200232

O=C1CC(c2cc3cc(Cl)ccc3o2)CN1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 4/20 0.45
KDM4E B2RXH2 5/20 0.40
GPR35 Q9HC97 2/20 0.40
ALDH1A1 P00352 2/20 0.40
CYP1A2 P05177 2/20 0.40
CYP2C9 P11712 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
KMT2A Q03164 2/20 0.40
CA1 P00915 2/20 0.40
CA2 P00918 2/20 0.40
CA12 O43570 1/20 0.40
CA9 Q16790 1/20 0.40
CYP2C19 P33261 1/20 0.39
HSD17B10 Q99714 1/20 0.38
MTNR1A P48039 1/20 0.38
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
MEN1 O00255 1/20 0.36
GAA P10253 1/20 0.36
TSHR P16473 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9315800 0.83 ALDH1A1 (0.43) MAOBALDH1A1CYP1A2CA1CA2
SCHEMBL9201848 0.83 CYP2A6 (0.41) GPR35ALDH1A1CYP1A2CA1CA2
SCHEMBL9202060 0.83 CA12 (0.40) ALDH1A1CYP1A2CA1CA2CA12
SCHEMBL9195715 0.81 ACHE (0.55) MAOBKDM4EALDH1A1CYP1A2CYP2C19
SCHEMBL9197524 0.80 TSHR (0.39) ALDH1A1CYP1A2CYP2C19MTNR1ATSHR
SCHEMBL9315699 0.80 PIM1 (0.44) MAOBALDH1A1CYP1A2CYP2C19MTNR1A
SCHEMBL9315026 0.80 ACHE (0.41) ALDH1A1CYP1A2CA2CA12CA9
SCHEMBL23175680 0.77 ACHE (0.50) MAOBKDM4EGPR35ALDH1A1CYP1A2
SCHEMBL9316757 0.76 PDE4A (0.38) ALDH1A1CYP1A2CYP2C19MTNR1AGAA
SCHEMBL23175437 0.74 MAOB (0.46) MAOBKDM4EGPR35ALDH1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0463969-B1 New compounds of 4-aminobutyric acid, process for their preparation and pharmaceutical preparations containing them ADIR (FR) 1995-02-08 EP disclosed
US-5278166-A 4-amino-3-heteroaryl butyric acid compounds, compositions, and their use for treating disorders involving a dysfunction of GABAB receptors ADIR ET COMPAGNIE (FR) 1994-01-11 US disclosed
US-5214063-A 4-aminobutyric acid compounds, compositions and methods of use for treating disorders related to a dysfunction of GABAB receptors ADIR ET COMPAGNIE (FR) 1993-05-25 US disclosed
US-5162364-A Treatment of spastic and senescence disorders ADIR ET COMPAGNIE (FR) 1992-11-10 US disclosed
EP-0463969-A1 New compounds of 4-aminobutyric acid, process for their preparation and pharmaceutical preparations containing them ADIR ET COMPAGNIE (FR) 1992-01-02 EP disclosed